Table 3.

Cytogenetic profile of CML-BC patients.

Sl. No	Recurrent karyotype	No. of cases
1	46,XY,t(9;22)(q34;q11)[20]	21
2	46,XX,t(9;22)(q34;q11)[20]	4
3	47,XX,t(9;22)(q34;q11),+der(22)t(9;22)[20]	1
4	47,XX,t(9;22)(q34;q11),+der(22)t(9;22)[10]/46,XX,t(9;22)(q34;q11)[10]	1
5	47,XY,t(9;22)(q34;q11),+der(22)t(9;22)[20]	2
6	47,XY,t(9;22)(q34;q11),+der(22)t(9;22)[16]/46,XY,t(9;22)(q34;q11)[4]	1
7	48,XY,t(3;21)(q26;q22),t(9;22)(q34;q11),+der(22)t(9;22),+12[20]	1
8	47,XY,+8,t(9;22)(q34;q11)[20]	2
9	46,XX,t(9;22)(q34;q11)[12]/45,XX,t(9;22)(q34;q11),−10[8]	1
10	49,XX,+9,t(9;22)(q34;q11),dup(16)(q24),+21,+der(22)t(9;22)[20]	1
11	Moderate hyperdiploidy, 2n = 47–50[20]	1
12	High hyperdiploidy, 2n = 51–65[20]	1
13	Moderate hyperdiploidy, 2n = 47–50[11]/92 <4n>,XXYY[9]	1
14	High hyperdiploidy, 2n = 51–65[20]	1
15	46,XX,t(9;22)(q34;q11)[15]/High hyperdiploidy[5]	1
16	46,XY,t(9;22)(q34;q11)[9]/48,XY,t(9;22)(q34;q11),+18,+der(22)t(9;22) [7]/92 <4n>,XXYY[4]	1
17	46,XX, t(9;22)(q34;q11)[11]/69 <3n>XXX[9]	1
18	46,XY,t(9;22)(q34;q11)[11]69 <3n>XXY[9]	1
19	Karyotype Failure	9
RARE KARYOTYPE
20	45,XX,der(7)t(7;8)(p?;q?),−8,t(9;22)(q34;q11)[20]	1
21	45,XX,−8,t(9;22;1)(q34;q11;q12)[20]	1
22	46,XX,t(9;22;6)(q34;q11;q25)[20]	1
NOVEL KARYOTYPE
23	47,XY,der(7)t(7;9)(p11.2;q11)t(9;22)(q34;q11),der(9)t(1;9)(q32;q11),+mar[20]	1
24	46,XY,inv(2)(p14q21),t(9;22)(q34;q11)[20]	1
25	44,XY,der(7)t(5;7)(q21;p11.2),t(9;22)(q34;q11),−10,−19[20]	1
26	49,XY,der(1)t(1;17)(p36.3;q25),+6,t(9;22)(q34;q11),+der(17)t(6;17)(q22;q25) × 2[20]	1
27	46,X,t(X;4)(q21;q34),t(9;22)(q34;q11)[20]	1